Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 7, Pages 58-63
http://dx.doi.org/10.1100/tsw.2007.223
Mini-Review Article

A Novel Dopamine Receptor Signaling Unit in Brain: Heterooligomers of D1 And D2 Dopamine Receptors

1Department of Pharmacology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
2Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada
3Centre for Addiction and Mental Health, Toronto, Ontario M5S 1A8, Canada

Received 23 July 2007; Revised 1 August 2007; Accepted 3 August 2007

Academic Editors: D. Shurtleff and S. Ferre

Copyright © 2007 Susan George and Brian F. O'Dowd.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Amina S. Woods, Daniel Marcellino, Shelley N. Jackson, Rafael Franco, Sergi Ferré, Luigi F. Agnati, and Kjell Fuxe, “How calmodulin interacts with the adenosine A2A and the dopamine D2 Receptors,” Journal of Proteome Research, vol. 7, no. 8, pp. 3428–3434, 2008. View at Publisher · View at Google Scholar
  • Sigeng Chen, Geoffrey C. Owens, and David B. Edelman, “Dopamine inhibits mitochondrial motility in hippocampal neurons,” PLoS ONE, vol. 3, no. 7, 2008. View at Publisher · View at Google Scholar
  • Takahide Shuto, Philip Seeman, Mahomi Kuroiwa, and Akinori Nishi, “ Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1 High and D2 High receptors in methamphetamine-sensitized rats ,” European Journal of Neuroscience, vol. 27, no. 10, pp. 2551–2557, 2008. View at Publisher · View at Google Scholar
  • Farah Khan, Zuzana Špicarová, Sergey Zelenin, Ulla Holtbäck, Lena Scott, and Anita Aperia, “Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells,” American Journal of Physiology - Renal Physiology, vol. 295, no. 4, pp. F1110–F1116, 2008. View at Publisher · View at Google Scholar
  • Anna M. Lee, and Robert O. Messing, “Protein kinases and addiction,” Annals of the New York Academy of Sciences, vol. 1141, pp. 22–57, 2008. View at Publisher · View at Google Scholar
  • Vicent Casadó, Antoni Cortés, Josefa Mallol, Kamil Pérez-Capote, Sergi Ferré, Carmen Lluis, Rafael Franco, and Enric I. Canela, “GPCR homomers and heteromers: A better choice as targets for drug development than GPCR monomers?,” Pharmacology and Therapeutics, vol. 124, no. 2, pp. 248–257, 2009. View at Publisher · View at Google Scholar
  • Marie-Noëlle Raymond, Philippe Robin, Federica De Zen, Ginette Vilain, and Zahra Tanfin, “Differential endothelin receptor expression and function in rat myometrial cells and leiomyoma ELT3 cells,” Endocrinology, vol. 150, no. 10, pp. 4766–4776, 2009. View at Publisher · View at Google Scholar
  • Kathleen Van Craenenbroeck, Dasiel O. Borroto-Escuela, Wilber Romero-Fernandez, Kamila Skieterska, Pieter Rondou, Béatrice Lintermans, Peter Vanhoenacker, Kjell Fuxe, Francisco Ciruela, and Guy Haegeman, “Dopamine D4 receptor oligomerization - contribution to receptor biogenesis,” FEBS Journal, vol. 278, no. 8, pp. 1333–1344, 2011. View at Publisher · View at Google Scholar
  • K. Kurokawa, M. Shibasaki, K. Mizuno, and S. Ohkuma, “Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α2/δ-1 subunits of the voltage-gated calcium channels,” Neuroscience, vol. 176, pp. 328–335, 2011. View at Publisher · View at Google Scholar
  • Ling Zhang, Hui Yang, Huanying Zhao, and Chunli Zhao, “Calcium-related signaling pathways contributed to dopamine-induced cortical neuron apoptosis,” Neurochemistry International, vol. 58, no. 3, pp. 281–294, 2011. View at Publisher · View at Google Scholar
  • Rudi Hwang, Renan P Souza, Arun K Tiwari, Clement C Zai, Daniel J Müller, Steven G Potkin, Jeffrey A Lieberman, Herbert Y Meltze, and James L Kennedy, “Gene–gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response,” Pharmacogenomics, vol. 12, no. 2, pp. 277–291, 2011. View at Publisher · View at Google Scholar
  • Yan-Chun Li, and Wen-Jun Gao, “GSK-3β activity and hyperdopamine-dependent behaviors,” Neuroscience & Biobehavioral Reviews, vol. 35, no. 3, pp. 645–654, 2011. View at Publisher · View at Google Scholar
  • Ahmed Hasbi, Brian F O'Dowd, and Susan R George, “Dopamine D1-D2 receptor heteromer signaling pathway in the brain: Emerging physiological relevance,” Molecular Brain, vol. 4, no. 1, 2011. View at Publisher · View at Google Scholar
  • Yan-Chun Li, Min-Juan Wang, and Wen-Jun Gao, “Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors,” Journal of Neurochemistry, vol. 122, no. 2, pp. 308–320, 2012. View at Publisher · View at Google Scholar
  • Sudarat Nimitvilai, Devinder S. Arora, and Mark S. Brodie, “Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C,” Neuropsychopharmacology, vol. 37, no. 2, pp. 543–556, 2012. View at Publisher · View at Google Scholar
  • Kjell Fuxe, Jose Angel Narvaez, Francisco Ciruela, Michele Guescini, Luigi F. Agnati, Dasiel O. Borroto-Escuela, Wilber Romero-Fernandez, Zaida Diaz-Cabiale, Alicia Rivera, Luca Ferraro, Sergio Tanganelli, Alexander O. Tarakanov, and Pere Garriga, “Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks,” Frontiers in Physiology, vol. 3, 2012. View at Publisher · View at Google Scholar
  • Kjell Fuxe, Dasiel O Borroto-Escuela, Wilber Romero-Fernandez, Miklós Palkovits, Alexander O Tarakanov, Francisco Ciruela, and Luigi F Agnati, “Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Melissa L Perreault, Ahmed Hasbi, Brian F O'Dowd, and Susan R George, “Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Kjell Fuxe, Diego Guidolin, Luigi F Agnati, and Dasiel O Borroto-Escuela, “Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease,” Expert Opinion on Therapeutic Targets, pp. 1–22, 2014. View at Publisher · View at Google Scholar
  • Ahmed Hasbi, Melissa L. Perreault, Maurice Y. F. Shen, Lucia Zhang, Ryan To, Theresa Fan, T Tuan Nguyen, Xiaodong Ji, Brian F. O'Dowd, and Susan R. George, “A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism,” Faseb Journal, vol. 28, no. 11, pp. 4806–4820, 2014. View at Publisher · View at Google Scholar
  • Pierre Trifilieff, and Diana Martinez, “Cocaine,” The Effects of Drug Abuse on the Human Nervous System, pp. 103–133, 2014. View at Publisher · View at Google Scholar
  • Kjell Fuxe, Dasiel O. Borroto-Escuela, Alexander O. Tarakanov, Wilber Romero-Fernandez, Luca Ferraro, Sergio Tanganelli, Mileidys Perez-Alea, Michael Di Palma, and Luigi F. Agnati, “Dopamine D2 heteroreceptor complexes and their receptor–receptor interactions in ventral striatum,” Dopamine, vol. 211, pp. 113–139, 2014. View at Publisher · View at Google Scholar
  • Susan R. George, Andras Kern, Roy G. Smith, and Rafael Franco, “Dopamine receptor heteromeric complexes and their emerging functions,” Dopamine, vol. 211, pp. 183–200, 2014. View at Publisher · View at Google Scholar
  • Kjell Fuxe, Dasiel O Borroto-Escuela, Francisco Ciruela, Diego Guidolin, and Luigi F Agnati, “Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory,” Neuroscience Discovery, vol. 2, no. 1, pp. 6, 2014. View at Publisher · View at Google Scholar
  • Mengia-Seraina Rioult-Pedotti, Ana Pekanovic, Clement Osei Atiemo, John Marshall, and Andreas Ruediger Luft, “Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation,” Plos One, vol. 10, no. 5, 2015. View at Publisher · View at Google Scholar
  • Gangsoo Jung, Eun-Jung Kim, Ana Cicvaric, Sunetra Sase, Marion Gröger, Harald Höger, Fernando Jayson Sialana, Johannes Berger, Francisco J. Monje, and Gert Lubec, “Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus,” Journal of Neurochemistry, 2015. View at Publisher · View at Google Scholar
  • Simon A. Sharples, Jennifer M. Humphreys, A. Marley Jensen, Sunny Dhoopar, Nicole Delaloye, Stefan Clemens, and Patrick J. Whelan, “Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord,” Journal Of Neurophysiology, vol. 113, no. 7, pp. 2500–2510, 2015. View at Publisher · View at Google Scholar
  • Ephrem Engidawork, Jana Aradska, and Gert Lubec, “Neurotransmitter receptor complexes: methods for bioanalysis, their potentials and limitations,” Reviews in the Neurosciences, no. 0, 2015. View at Publisher · View at Google Scholar
  • Eyleen Corrales, Arcadi Navarro, Patricia Cuenca, and Domingo Campos, “Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression,” Psychiatry Research, 2016. View at Publisher · View at Google Scholar
  • Dasiel O. Borroto-Escuela, Karolina Wydra, Luca Ferraro, Alicia Rivera, Malgorzata Filip, and Kjell Fuxe, “Role of D2-like Heteroreceptor Complexes in the Effects of Cocaine, Morphine, and Hallucinogens,” Neuropathology of Drug Addictions and Substance Misuse, pp. 93–101, 2016. View at Publisher · View at Google Scholar
  • Ewa Błasiak, Sylwia Łukasiewicz, Kinga Szafran-Pilch, and Marta Dziedzicka-Wasylewska, “Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor,” Pharmacological Reports, vol. 69, no. 2, pp. 235–241, 2017. View at Publisher · View at Google Scholar
  • Kamila Skieterska, Pieter Rondou, and Kathleen Van Craenenbroeck, “Regulation of G Protein-Coupled Receptors by Ubiquitination,” International Journal of Molecular Sciences, vol. 18, no. 5, pp. 923, 2017. View at Publisher · View at Google Scholar
  • Batoul Farran, “An update on the physiological and therapeutic relevance of GPCR oligomers,” Pharmacological Research, vol. 117, pp. 303–327, 2017. View at Publisher · View at Google Scholar
  • Dasiel O. Borroto-Escuela, Miguel Perez De La Mora, Paul Manger, Manuel Narváez, Sarah Beggiato, Minerva Crespo-Ramírez, Gemma Navarro, Karolina Wydra, Zaida Díaz-Cabiale, Alicia Rivera, Luca Ferraro, Sergio Tanganelli, Małgorzata Filip, Rafael Franco, and Kjell Fuxe, “Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors,” Frontiers in Synaptic Neuroscience, vol. 10, 2018. View at Publisher · View at Google Scholar
  • Dasiel O. Borroto-Escuela, Alexander O. Tarakanov, Ismel Brito, and Kjell Fuxe, “Glutamate heteroreceptor complexes in the brain,” Pharmacological Reports, vol. 70, no. 5, pp. 936–950, 2018. View at Publisher · View at Google Scholar